Stock Research: Bumrungrad Hospital

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Bumrungrad Hospital

SET:BH TH0168A10Z01
75
  • Value
    98
  • Growth
    9
  • Safety
    Safety
    37
  • Combined
    51
  • Sentiment
    95
  • 360° View
    360° View
    75
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Bumrungrad Hospital Public Company Limited is a healthcare provider offering holistic services to outpatients and inpatients. It primarily operates a private hospital in Bangkok, providing a wide range of healthcare services including Telemedicine, preventive genomics, family check-ups, Bumrungrad@Home services, breast health, and sports medicine. It operates in Thailand and Southeast Asia. In the last fiscal year, the company had a market cap of $3531 million, profits of $383 million, revenue of $748 million, and 4234 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 75 (better than 75% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Bumrungrad Hospital are very positive. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Bumrungrad Hospital. The consolidated Sentiment Rank has a good rank of 95, which means that professional investors are more optimistic about the stock than for 95% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 98 or better than 98% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 37, meaning that the share price of Bumrungrad Hospital is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 9. ...read more

more
Index
SET
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
37 37 30 19
Growth
9 19 61 57
Safety
Safety
98 100 100 60
Sentiment
95 63 96 72
360° View
360° View
75 63 96 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
53 55 44 19
Opinions Change
76 36 56 67
Pro Holdings
n/a 61 100 46
Market Pulse
92 94 95 89
Sentiment
95 63 96 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
37 37 30 19
Growth
9 19 61 57
Safety Safety
98 100 100 60
Combined
51 55 88 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
52 55 43 9
Price vs. Earnings (P/E)
30 27 14 13
Price vs. Book (P/B)
26 21 15 22
Dividend Yield
72 78 76 75
Value
37 37 30 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
8 4 4 84
Profit Growth
25 25 75 17
Capital Growth
30 98 100 38
Stock Returns
17 19 37 55
Growth
9 19 61 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
95 98 96 70
Refinancing
52 51 47 39
Liquidity
98 98 98 53
Safety Safety
98 100 100 60

Similar Stocks

Discover high‑ranked alternatives to Bumrungrad Hospital and broaden your portfolio horizons.

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

PTT Oil and Retail

SET:OR
Country: Thailand
Industry: Automotive Retail
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.